
Greenwich LifeSciences Inc is a biopharmaceutical company that is developing GP2, an immunotherapy designed to prevent the recurrence of breast cancer following surgery. GP2 is a 9 amino acid transmembrane peptide of the HER2/neu protein, a cell surface receptor protein that is expressed in a variet... Greenwich LifeSciences Inc is a biopharmaceutical company that is developing GP2, an immunotherapy designed to prevent the recurrence of breast cancer following surgery. GP2 is a 9 amino acid transmembrane peptide of the HER2/neu protein, a cell surface receptor protein that is expressed in a variety of common cancers, including expression in most breast cancers at low, intermediate, and high or overexpressor levels. 더 보기
기간 | 변동 | 변동 % | 시가 | 고가 | 저가 | 평균 일일 거래량 | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -1.31 | -12.2889305816 | 10.66 | 11.1285 | 9.06 | 50504 | 9.84685676 | CS |
4 | -2.7613 | -22.7993691842 | 12.1113 | 13.33 | 9.06 | 38326 | 10.86693999 | CS |
12 | -4.45 | -32.2463768116 | 13.8 | 14.41 | 9.06 | 31904 | 11.79309976 | CS |
26 | -4.9083 | -34.424159963 | 14.2583 | 15.47 | 9.06 | 30321 | 12.56576855 | CS |
52 | -8.66 | -48.0843975569 | 18.01 | 18.7499 | 9.06 | 35188 | 14.08549264 | CS |
156 | -10.35 | -52.538071066 | 19.7 | 21.5 | 6.8241 | 59459 | 11.85041241 | CS |
260 | 4.35 | 87 | 5 | 158.07 | 3.262 | 136812 | 35.76447308 | CS |
귀하가 조회한 주식이 이 박스에 나타나며 쉽게 최근 시세로 돌아갈 수 있습니다.
도움 및 지원받기: kr-support@advfn.com
ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관